Mostrando 7 resultados de: 7
Filtros aplicados
Subtipo de publicación
Article(7)
Publisher
Pharmacology Biochemistry and Behavior(2)
Behavioural Brain Research(1)
Current Pharmaceutical Design(1)
Developmental Psychobiology(1)
Frontiers in Behavioral Neuroscience(1)
Área temáticas
Farmacología y terapéutica(6)
Enfermedades(4)
Fisiología humana(2)
Temas específicos de historia natural de los animales(2)
Ginecología, obstetricia, pediatría, geriatría(1)
Área de conocimiento
Farmacología(2)
Neuropsicología(2)
Biología del desarrollo(1)
Fisiología(1)
Neurología(1)
Objetivos de Desarrollo Sostenible
ODS 3: Salud y bienestar(7)
ODS 10: Reducción de las desigualdades(5)
ODS 4: Educación de calidad(5)
ODS 2: Hambre cero(2)
ODS 12: Producción y consumo responsables(1)
Origen
scopus(7)
A pharmacokinetic model of oral methylphenidate in the rat and effects on behavior
ArticleAbstract: Most animal studies using methylphenidate (MP) do not administer it the same way it is administeredPalabras claves:Attention Deficit Hyperactivity Disorder, Dopamine transporter, methylphenidate, Psychostimulant, ritalinAutores:Cooper T., David Edward Komatsu, Hadjiargyrou M., Hwang Y., Robison L.S., Steier J., Swanson J.M., Thanos P.K., Volkow N.D.Fuentes:scopusChronic oral methylphenidate treatment increases microglial activation in rats
ArticleAbstract: Methylphenidate (MP) is a widely prescribed psychostimulant used to treat attention deficit hyperactPalabras claves:Attention Deficit Hyperactivity Disorder, Autoradiography, inflammation, methylphenidate, Microglia, ritalinAutores:Carias E., David Edward Komatsu, Delis F., Eiden R., Hadjiargyrou M., Hamilton J., Quattrin T., Robison L.S., Thanos P.K.Fuentes:scopusBrief and extended abstinence from chronic oral methylphenidate treatment produces reversible behavioral and physiological effects
ArticleAbstract: Methylphenidate (MP) is a commonly prescribed psychostimulant to individuals with Attention DeficitPalabras claves:anxiety, Attention Deficit Hyperactivity Disorder, methylphenidate, Psychostimulant, ritalinAutores:Carias E., Connor C., David Edward Komatsu, Hadjiargyrou M., Kalinowski L., Mackintosh M., Martin C., Popoola D., Richer K., Smith L., Somanesan R., Thanos P.K.Fuentes:scopusAbstinence from Chronic Methylphenidate Exposure Modifies Cannabinoid Receptor 1 Levels in the Brain in a Dose-dependent Manner
ArticleAbstract: Introduction: Methylphenidate (MP) is a widely used psychostimulant prescribed for Attention DeficitPalabras claves:Attention Deficit Hyperactivity Disorder, Cannabinoid receptor 1, Endocannabinoid system, methylphenidate, Psychostimulant, ritalinAutores:Connor C., David Edward Komatsu, Hadjiargyrou M., Hamilton J., Robison L.S., Thanos P.K.Fuentes:scopusRecovery from behavior and developmental effects of chronic oral methylphenidate following an abstinence period
ArticleAbstract: Chronic oral methylphenidate (MP) exposure in rats is associated with numerous developmental and behPalabras claves:anxiety, Attention Deficit Hyperactivity Disorder, methylphenidate, Psychostimulant, ritalin, SensitizationAutores:David Edward Komatsu, Fricke D., Hadjiargyrou M., Koutsomitis D., Lowinger C., Martin C., Popoola D., Thanos P.K., Vijayashanthar A.Fuentes:scopusSex differences in the physiological and behavioral effects of chronic oral methylphenidate treatment in rats
ArticleAbstract: Methylphenidate (MP) is a psychostimulant prescribed for Attention Deficit Hyperactivity Disorder. PPalabras claves:Attention Deficit Hyperactivity Disorder, methylphenidate, Psychostimulant, ritalin, Sensitization, Sex differencesAutores:David Edward Komatsu, Fricke D., Gandhi J., Hadjiargyrou M., Lam C., Lee J., Mauceri A., Miao E., Michaelos M., Paeng S., Robison L.S., Thanos P.K., Vitale M.Fuentes:scopusWeekday-only chronic oral methylphenidate self-administration in male rats: Reversibility of the behavioral and physiological effects
ArticleAbstract: Methylphenidate (MP) is a commonly prescribed psychostimulant for Attention Deficit Hyperactivity DiPalabras claves:anxiety, Attention Deficit Hyperactivity Disorder, Depression, methylphenidate, Psychostimulant, ritalin, SOCIAL BEHAVIORAutores:Carias E., David Edward Komatsu, Fricke D., Hadjiargyrou M., Kalinowski L., Martin C., Popoola D., Smith L., Somanesan R., Thanos P.K., Vijayashanthar A.Fuentes:scopus